Aug 10, 2026 09:10AM
Aug 5, 2026 04:06PM
Aug 5, 2026 04:05PM
Jul 7, 2026 04:05PM
May 12, 2026 09:27AM
May 11, 2026 04:06PM
May 11, 2026 04:05PM AbCellera reports positive phase 1 data for menopause drug ABCL635
May 11, 2026 04:05PM
Apr 20, 2026 09:00AM
Apr 20, 2026 09:00AM
Apr 1, 2026 04:05PM
Feb 24, 2026 04:15PM
Feb 24, 2026 04:05PM
Jan 22, 2026 04:05PM AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
Nov 6, 2025 04:10PM
Nov 6, 2025 04:05PM
Sep 29, 2025 04:05PM
Aug 13, 2025 10:05AM
Aug 7, 2025 04:23PM
Aug 7, 2025 04:22PM
Aug 7, 2025 04:05PM AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
Jul 7, 2025 04:05PM
May 8, 2025 04:05PM
May 8, 2025 04:05PM
Apr 3, 2025 04:05PM
Mar 3, 2025 09:41AM
Feb 27, 2025 04:19PM
Feb 27, 2025 04:05PM AbCellera Reports Full Year 2024 Business Results
Jan 21, 2025 04:05PM
Nov 4, 2024 04:08PM
Nov 4, 2024 04:05PM
Sep 26, 2024 04:05PM
Aug 20, 2024 09:15AM
Aug 6, 2024 04:08PM
Aug 6, 2024 04:05PM AbCellera Reports Q2 2024 Business Results
Jun 28, 2024 10:34AM
Jun 25, 2024 04:05PM
May 7, 2024 04:06PM
May 7, 2024 04:05PM
Apr 3, 2024 04:05PM
Feb 22, 2024 09:40AM
Feb 20, 2024 04:07PM AbCellera (ABCL) Misses Q4 EPS by 5c
Feb 20, 2024 04:05PM
Jan 23, 2024 04:05PM
Nov 2, 2023 04:46PM
Nov 2, 2023 04:05PM
Oct 11, 2023 04:05PM
Aug 3, 2023 04:07PM
Aug 3, 2023 04:05PM AbCellera Reports Q2 2023 Business Results
Jul 6, 2023 04:05PM

1,216,595 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All